Proventus Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 7.00 Cr
as on 27-12-2022
- Paid Up Capital ₹ 5.58 Cr
as on 27-12-2022
- Company Age 45 Year, 5 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 34.89 Cr
as on 27-12-2022
- Satisfied Charges ₹ 38.46 Cr
as on 27-12-2022
- Revenue -24.55%
(FY 2021)
- Profit -39.00%
(FY 2021)
- Ebitda 105.85%
(FY 2021)
- Net Worth 1.25%
(FY 2021)
- Total Assets -46.15%
(FY 2021)
About Proventus Life Sciences
The Corporate was formerly known as Curekrafts Chemicals (I) P Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 7.00 Cr and a paid-up capital of Rs 5.58 Cr.
The company currently has active open charges totaling ₹34.89 Cr. The company has closed loans amounting to ₹38.46 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ashok Dasgupta, Archana Singhania, Debashish Datta, and One other member serve as directors at the Company.
- CIN/LLPIN
U24211WB1979PTC206988
- Company No.
206988
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jun 1979
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc-Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Proventus Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Dasgupta  | Managing Director | 19-Sep-2022 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Debashish Datta | Director | 19-Sep-2022 | Current |
| Ayush Sultania | Director | 01-Aug-2022 | Current |
| Archana Singhania | Director | 01-Aug-2022 | Current |
Financial Performance and Corporate Structure Insights of Proventus Life Sciences.
Proventus Life Sciences Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 24.55% decrease. The company also saw a substantial fall in profitability, with a 39% decrease in profit. The company's net worth moved up by a moderate rise of 1.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Proventus Life Sciences?
In 2021, Proventus Life Sciences had a promoter holding of 95.34% and a public holding of 4.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Lakewater Technologies LimitedActive 2 years 9 months
Archana Singhania and Ayush Sultania are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Julius Baer Capital (India) Private Limited Creation Date: 21 Sep 2022 | ₹19.00 Cr | Open |
Icici Bank Limited Creation Date: 17 Mar 2022 | ₹15.50 Cr | Open |
The Tamilnadu Industrial Investmentcorporation Ltd. Creation Date: 04 Nov 1989 | ₹2.73 M | Open |
How Many Employees Work at Proventus Life Sciences?
Proventus Life Sciences has a workforce of 68 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Proventus Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Proventus Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
